-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SZgXkSsGTAWHEvpdkVc5P1sdYYpHuis+RK6/FlNrSZvs54ChIrf3AQm6fXTNysda jNzUeP1IpO5yGpeU+mjSoA== 0000950135-99-000665.txt : 19990215 0000950135-99-000665.hdr.sgml : 19990215 ACCESSION NUMBER: 0000950135-99-000665 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990212 GROUP MEMBERS: ANNETTE BAUMGARTNER GROUP MEMBERS: BAUMGARTNER WERNER A SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHEMEDICS CORP CENTRAL INDEX KEY: 0000806517 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 581701987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-39145 FILM NUMBER: 99533558 BUSINESS ADDRESS: STREET 1: 1280 MASSACHUSETTS AVENUE STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 6178687455 MAIL ADDRESS: STREET 1: 1280 MASSACHUSETTS AVE STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02138 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAUMGARTNER WERNER A CENTRAL INDEX KEY: 0000900595 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 5832 UPLANDER WAY CITY: CULVER CITY STATE: CA ZIP: 90230 BUSINESS PHONE: 3102167776 MAIL ADDRESS: STREET 1: 5832 UPLANDER WAY CITY: CULVER CITY STATE: CA ZIP: 90230 SC 13G/A 1 PSYCHEMEDICS CORPORATION 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 11) PSYCHEMEDICS CORPORATION - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK - $.005 Par Value - -------------------------------------------------------------------------------- 744375106 - -------------------------------------------------------------------------------- (CUSIP Number) (Continued on the following pages) Page 1 of 6 Pages 2 - -------------------- ------------ CUSIP No. 744375106 SCHEDULE 13G Page 2 of 6 - ------------------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS; S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Werner A. Baumgartner - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)[ ] (b)[X] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER 89,900 -------------------------------------------------- NUMBER OF 6. SHARED VOTING POWER SHARES 1,226,820 BENEFICIALLY -------------------------------------------------- OWNED BY 7. SOLE DISPOSITIVE POWER EACH 89,900 REPORTING -------------------------------------------------- PERSON WITH: 8. SHARED DISPOSITIVE POWER 1,226,820 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORT PERSON 1,316,720 - -------------------------------------------------------------------------------- 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.9% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN ================================================================================ *SEE INSTRUCTIONS BEFORE FILING OUT! 3 - -------------------- ------------- CUSIP No. 744375106 SCHEDULE 13G Page 3 of 6 - ------------------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS; S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS ANNETTE BAUMGARTNER - ------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a)[ ] (b)[x] - ------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER 0 NUMBER OF ------------------------------------------------- SHARES 6. SHARES VOTING POWER BENEFICIALLY 1,226,820 OWNED BY ------------------------------------------------- EACH 7. SOLE DISPOSITIVE POWER REPORTING 0 PERSON WITH: ------------------------------------------------- 8. SHARED DISPOSITIVE POWER 1,226,820 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,226,820 - -------------------------------------------------------------------------------- 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.5% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN ================================================================================ *SEE INSTRUCTIONS BEFORE FILLING OUT! 4 Page 4 SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G AMENDMENT NO. 11 ITEM 1(a) NAME OF ISSUER: Psychemedics Corporation (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 1280 Massachusetts Avenue Cambridge, Massachusetts 02138 ITEM 2(a) NAME OF PERSON FILING: Werner and Annette Baumgartner (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 5832 Uplander Way Culver City, CA 90230 (c) CITIZENSHIP: USA (d) TITLE OF CLASS OF SECURITIES, Common Stock, $.005 par value (e) CUSIP NUMBER: 744375106 ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(b), OR 13d-2(b), CHECK WHETHER THE PERSON FILING IS A: Not Applicable ITEM 4 AMOUNT BENEFICIALLY OWNED: Dr. Baumgartner is the beneficial owner of 51,500 shares of Common Stock of the issuer and options to acquire 38,400 shares of Common Stock of the issuer. Dr. and Mrs. Baumgartner are trustees of a family trust, a charitable trust and a medical fund trust which own an aggregate of 1,226,820 shares of Common Stock of the issuer. The Baumgartners together beneficially own an aggregate of 1,316,720 shares of Common Stock of the issuer, representing 5.9% of the outstanding shares of the issuer. 5 Page 5 ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not Applicable ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not Applicable ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not Applicable ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: This Schedule 13G is being filed by Werner and Annette Baumgartner. Dr.and Mrs. Baumgartner each expressly disclaims beneficial ownership of the securities held by the other, and each disclaims the existence of a group. ITEM 9 NOTICE OF DISSOLUTION OF GROUP: Not Applicable ITEM 10 CERTIFICATION Not Applicable 6 Page 6 After reasonable inquiry and to the best of my knowledge and belief, I hereby certify that the information set forth in this statement is true, complete and correct. February 12, 1999 ------------------------------------------ Date /s/ Werner A. Baumgartner ------------------------------------------ Signature Werner A. Baumgartner ------------------------------------------ Name/Title /s/ Annette Baumgartner ------------------------------------------ Signature Annette Baumgartner ------------------------------------------ Name/Title -----END PRIVACY-ENHANCED MESSAGE-----